Condensed Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2025	Dec. 31, 2024
OPERATING EXPENSES
Research and development	$ 1,118,649	$ 1,156,351	$ 2,111,715	$ 3,089,442
General and administrative	1,114,525	902,700	1,918,144	2,137,443
Total operating expenses	2,233,174	2,059,051	4,029,859	5,226,885
LOSS FROM OPERATIONS	(2,233,174)	(2,059,051)	(4,029,859)	(5,226,885)
OTHER INCOME (EXPENSE)
Interest income	12,455	31,709	24,082	72,732
Interest expense		(149)		(149)
Other income, net	12,455	31,560	24,082	72,583
NET LOSS	$ (2,220,719)	$ (2,027,491)	$ (4,005,777)	$ (5,154,302)
Net loss per common share/Weighted average common shares outstanding
Net loss per common share - basic	$ (0.11)	$ (0.14)	$ (0.22)	$ (0.36)
Net loss per common share - diluted	$ (0.11)	$ (0.14)	$ (0.22)	$ (0.36)
Weighted average common shares outstanding - basic	19,850,080	14,572,042	18,466,253	14,132,159
Weighted average common shares outstanding - diluted	19,850,080	14,572,042	18,466,253	14,132,159